Просмотр новости

Найдите то, что Вас интересует

FDA advisory committee for peptides stocked with conflicts of interest

Дата публикации: 01-07-2026 18:39:15

The FDA has listed its advisory members for the committee that will discuss peptides in late July.Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some of the most transformative drugs in modern medicine are peptides,” including insulin and semaglutide. While “the science of peptides is real, serious and worth pursuing,” Durrani wrote, the current system is messy: “a multi-billion-dollar market, a gray zone of unregulated suppliers, a regulatory system under political pressure, and real people spending real money on compounds that, for most of

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Combination GLP-1 and SGLT2 therapy may lower heart risk0525-06-2026
2How a rare kidney disease gained a robust new therapy pipeline3724-06-2026
3Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days0531-07-2025
4Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity7831-07-2025
5Obesity presents differently for men compared with women0501-07-2026
6USPSTF nears 1 year of silence, raising questions about HHS’ obligation to maintain it-2626-06-2026
7STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug0725-06-2026
8Песков: Путин в курсе ситуации с нехваткой льготных лекарств0010-10-2018
9Your favorite tech will keep getting more expensive, and you can blame AI-2628-06-2026
10Key Tips For Patenting Antibody-Drug Conjugate Inventions0530-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.healio.com.